(Legal Definition of Personal Use and Allowable Amounts of Cultivated Cannabis) "Policy changes in Belgium in relation to cannabis use, possession and cultivation may also have had some impact on the shift in production from the Netherlands to Belgium. In 2001, the Belgian government agreed to stop prosecution for use of cannabis and cultivation of cannabis for personal use, on the grounds that it did not constitute a nuisance and was not problematic (Decorte, 2007). However, it was not until 2003 that guidelines outlining what was permitted were implemented.
(Teen Marijuana Use in Medical Marijuana States) "Our results are not consistent with the hypothesis that the legalization of medical marijuana caused an increase in the use of marijuana and other substances among high school students. In fact, estimates from our preferred specifications are consistently negative and are never statistically distinguishable from zero."
(Medical Cannabis and the Constitution's Commerce Clause) "Congress has exercised its Commerce Clause authority to categorically ban marijuana.
(Cannabinoids and Multiple Sclerosis) "Using an objective measure, we saw a beneficial effect of inhaled cannabis on spasticity among patients receiving insufficient relief from traditional treatments. Although generally well-tolerated, smoking cannabis had acute cognitive effects. Larger, long-term studies are needed to confirm our findings and determine whether lower doses can result in beneficial effects with less cognitive impact."
(NIDA's Federal Medical Cannabis Program) "It is a judicial fluke that the National Institute on Drug Abuse has provided medical marijuana to a handful of patients (never more than 32, currently 4 surviving) as the outcome of the settlement in a lawsuit pressed in 1976 by a man with cannabis-responsive glaucoma. That settlement became the basis for the FDA’s Compassionate Investigational New Drug Study program for patients with marijuana responsive conditions. No patient has been enrolled since 1992, when the George H. W.
(Safety of Cannabis) "Generally, as analgesics, cannabinoids have minimal toxicity and present no risk of lethal overdose.48 End-organ failure secondary to medication effect has not been described and no routine laboratory monitoring is required in patients taking these medications."
(Cannabinoids and the Chemical Composition of Cannabis) "Essentially a herbal cannabinoid drug, the resin-secreting flowers of select varietals of the female cannabis plant contain approximately 6 dozen of different phytocannabinoids or plant-derived cannabinoids; these compounds are generally classified structurally as terpenophenolics with a 21-carbon molecular scaffold.24 Other compounds, such as terpenoids, flavonoids, and phytosterols, which are common to many other botanicals, are also produced by cannabis and have some demonstrated pharmacologic prop
(Ethics of Recommending Medical Cannabis to Patients) "Portions of the American Medical Association’s Code of Medical Ethics, Opinion 1.02 – The Relation of Law and Ethics reads, 'Ethical values and legal principles are usually closely related, but ethical obligations typically exceed legal duties.
(Estimated Prevalence of Cannabis Use Among Young Adults in the EU) "An estimated 16.6 million young Europeans (aged 15–34), or 13.3 % of this age group, used cannabis in the last year, with 9.6 million of these aged 15–24 (16.4 % of this age group). Among young people using cannabis in the last year, the ratio of males to females is two to one.